Rejuvel Bio-Sciences, Inc. (OTCBB:NUUU) announced that it has received $85,000 in a round of funding on July 24, 2015. The company entered into a securities purchase agreement for a private placement of a convertible debentures due 2018 with a private investor for gross proceeds of $636,500. The debenture would mature in 2018.

The debentures are convertible into company's common share at a conversion price equal to 60% of the lowest closing daily price common shares for the twenty consecutive trading days prior to conversion. The company issued the securities pursuant to exemption provided under Regulation D. The company expected to pay a non-accountable fee of $5,000 and legal fees of $2,500. The minimum investment accepted from any outside investor is $70,000.